跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-CAPTO TABLET 25 MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-CAPTO TABLET 25 MG
Approved
THERAPEUTIC
APO-CAPTO TABLET 25 MG
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Nov 14, 1991
Approval ID
c1f1918b8e903be9
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
c1f1918b8e903be9
Drug Name
APO-CAPTO TABLET 25 MG
Product Name
APO-CAPTO TABLET 25 MG
Approval Number
SIN06666P
Approval Date
1991-11-14
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C09AA01
Atc Item Name
captopril
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
CAPTOPRIL
25 mg
CAPTOPRIL
25 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 14, 1991
Approval ID
c1f1918b8e903be9
Type
Therapeutic
Back to HSA Approvals